William Pickering Analyst PerformanceAnalyst at ArgusWilliam Pickering is a stock analyst at Argus in the medical sector, covering 12 publicly traded companies. Over the past year, William Pickering has issued 27 stock ratings, including buy and hold recommendations. While full access to William Pickering's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights William Pickering's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings27 Last 0 YearsBuy Recommendations55.00% 11 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution20RatingsDistribution of strong buy, buy, hold, and sell ratings by William Pickering.RatingPercentageCount Strong Buy0.0%0 ratings Buy55.0%11 ratings Hold45.0%9 ratings Sell0.0%0 ratingsOut of 20 total stock ratings issued by William Pickering at Argus, the majority (55.0%) have been Buy recommendations, followed by 45.0% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ91.7% of companies on NASDAQ11 companiesNYSE8.3% of companies on NYSE1 companyWilliam Pickering, an analyst at Argus, currently covers 12 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical12 companies100.0%William Pickering of Argus specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE10 companies83.3%MED - GENERIC DRG1 company8.3%MED - DRUGS1 company8.3% William Pickering's Ratings History at Argus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBMRNBioMarin Pharmaceutical5/5/2026Lower Price Target$53.66$82.00Outperform$0.0000.00% ROIALLOAllogene Therapeutics4/14/2026Boost Price Target$3.04$3.85Market Perform$0.0000.00% ROIALLOAllogene Therapeutics4/14/2026Boost Price Target$2.63$3.85Market Perform$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/8/2026Lower Price Target$762.65$921.00Outperform$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/25/2026Boost Price Target$61.51$94.00Outperform$0.0000.00% ROIVRTXVertex Pharmaceuticals2/13/2026Reiterated Rating$487.66$577.00Outperform$0.0000.00% ROIBIIBBiogen2/9/2026Reiterated Rating$201.18Market Perform$0.0000.00% ROIBIIBBiogen2/9/2026Set Price Target$201.18$201.00$0.0000.00% ROIBIIBBiogen2/3/2026Set Price Target$179.09$191.00$0.0000.00% ROIBEAMBeam Therapeutics1/21/2026Set Price Target$31.99$41.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BEAMBeam Therapeutics1/20/2026Boost Price Target$30.97$41.00Outperform$0.0000.00% ROIVRTXVertex Pharmaceuticals1/12/2026Upgrade$463.86Outperform$0.0000.00% ROIBIIBBiogen1/9/2026Boost Price Target$168.57$197.00Market Perform$0.0000.00% ROIBBIOBridgeBio Pharma12/11/2025Initiated Coverage$72.70$94.00Outperform$0.0000.00% ROIBBIOBridgeBio Pharma12/11/2025Initiated Coverage$74.51$94.00Outperform$0.0000.00% ROIDYNDyne Therapeutics12/9/2025Set Price Target$19.19$23.00$0.0000.00% ROIBHVNBiohaven11/6/2025Reiterated Rating$8.31$9.00Market Perform$0.0000.00% ROIBIIBBiogen11/3/2025Set Price Target$151.30$157.00$0.0000.00% ROIBMRNBioMarin Pharmaceutical11/3/2025Set Price Target$53.57$88.00$0.0000.00% ROIBIIBBiogen11/3/2025Boost Price Target$154.27$157.00Market Perform$0.0000.00% ROIBMRNBioMarin Pharmaceutical11/3/2025Lower Price Target$53.57$88.00Outperform$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Set Price Target$14.79$14.50$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Downgrade$14.79$14.50Market Perform$0.0000.00% ROIRNAAvidity Biosciences10/27/2025Downgrade$49.15$72.00Market Perform$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/27/2025Boost Price Target$587.74$781.00Outperform$0.0000.00% ROISRPTSarepta Therapeutics7/29/2025Initiated Coverage$13.86$13.00Market Perform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
